[New Clinical Aspects of Behçet's Disease] (Q84600777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

8 February 2020

title

[New Clinical Aspects of Behçet's Disease] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Jenaro Graña Gil

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

8 February 2020

volume

4 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

50-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Behçet's syndrome: disease manifestations, management, and advances in treatment

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Vasculitis in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

MEFV mutations in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Association of the R92QTNFRSF1Amutation and extracranial deep vein thrombosis in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Autoinflammatory gene mutations in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

New approaches in the treatment of Adamantiades-Behçet's disease

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Dyslipidaemia in Behcet's disease as a thrombotic risk factor.

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Haemorheological alterations in Behçet's disease are not related to a tendency for venous thrombosis

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Activated protein C levels in Behçet's disease and risk of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Renal transplantation in a C-ANCA( ) patient with Behcet disease and rapidly progressive glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

[Left ventricular dysfunction associated with Behçet disease]

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

Behçet's disease involving the breast

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

[Behçet's disease in treatment with cyclosporine and seizures: diagnostic dilemma]

1 reference

https://api.crossref.org/works/10.1016/S1699-258X(08)76141-2

7 January 2021

10.1016/S1699-258X(08)76141-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794555 AND SRC:MED&resulttype=core&format=json

8 February 2020

1 reference